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Abstract 
Background:24-hour ambulatory blood pressure and heart rate monitoring  (24hr-ABPM) 
can provide vital information on circadian blood pressure (BP) profiles, which are commonly 
abnormal in Parkinson’s disease with and without autonomic failure (PD+AF and PD) and 
multiple system atrophy (MSA). 24hr-ABPM has not been directly compared between these 
disorders regarding cardiovascular autonomic function. We aim to determine the usefulness 
of 24hr-ABPM with diary compared to Head-up Tilting (HUT) in diagnosing orthostatic 
hypotension (OH) in these patients. 
Methods: 74 patients (23 MSA,18 PD+AF,33 PD) underwent cardiovascular autonomic 
screening followed by 24hr-ABPM with diary. Standing tests were included during 24hr-
ABPM. The sensitivity and specificity in detecting OH from the 24hr-ABPM standing test 
were compared with HUT. 
Results: There was no difference in OH during HUT between MSA and PD+AF (p>0.05). 
MSA and PD+AF had a higher proportion of abnormal BP circadian rhythms compared to 
PD (p<0.05) but not between MSA and PD+AF (p>0.05). Patients were divided into groups 
with (OH+) and without OH (OH-) on HUT. Using the standing test during 24hr-ABPM, a 
SBP fall of >20 mmHg showed a sensitivity and specificity of 82% and 100 % (AUC 0.91, 
95% CI 0.84-0.98) in differentiating OH+ from OH-, respectively.  
Conclusions:PD+AF and MSA patients had similar circadian BP patterns suggesting that 
autonomic dysfunction influences abnormal BP circadian patterns similarly in these 
disorders. The higher sensitivity and specificity in detecting OH using a SBP fall of >20 
mmHg compared to a DBP fall of >10 mmHg during standing test supports its usefulness to 
assess autonomic function in MSA and PD.  
Introduction 
24 hour-ambulatory blood pressure and heart rate monitoring (24hr-ABPM) is widely used in 
patients with hypertension and recent studies have demonstrated the usefulness of this 
equipment to detect and follow-up patients with hypertension (1). Furthermore, 24hr-ABPM 
offers information not only on daytime blood pressure (BP) but also circadian BP revealing 
key information on day- and night-time profiles. In normal subjects, BP is normally lower at 
night-time which has been described as nocturnal blood pressure ‘dipping’. This pattern can 
be absent or reversed (BP night-time>BP daytime) in patients with autonomic failure, such as 
multiple system atrophy. These patients tend to have lower BP during the day and a loss of 
BP dipping or even a higher BP at night, influenced by supine hypertension, a common 
occurrence in autonomic failure (2).  
24hr-ABPM is commonly reported as abnormal in patients with Parkinson’s Disease (PD) 
(5). The prevalence of non-dippers in PD ranges from 48 to 95% (5-7).  Abnormal nocturnal 
circadian falls in blood pressure occur more often in PD+AF compared to PD suggesting that 
there is a link between abnormal BP circadian rhythms and orthostatic hypotension (7). More 
recently, 24hr-ABPM was used among different forms of parkinsonian disorders, including 
multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) (5). The results 
showed that a number of these patients had a significantly higher proportion of absent 
nocturnal BP dipping compared to age-matched controls. These findings support the use of 
24hr ABPM for screening autonomic function when the autonomic laboratory is not available 
(5). Nevertheless, 24hr-ABPM has never been specifically compared in PD patients with and 
without autonomic failure and MSA patients with autonomic failure. Furthermore, the 
efficacy of 24hr-ABPM with an autonomic protocol diary in detecting orthostatic 
hypotension (OH), compared with laboratory head-up tilt-table testing in these patient 
groups, has also never been evaluated. Such information would help with the often difficult 
task of diagnosing OH in MSA and PD+AF and with the screening of autonomic function in 
the community setting. The aim of this study was, therefore, to 1) examine 24hr-ABPM in 
patients with MSA, PD+AF and PD and 2) determine the usefulness of 24hr-ABPM 
compared to standard orthostatic challenge testing (10 minute Head-up Tilt) in diagnosing 
orthostatic hypotension (OH) in these patients.  
Methods 
Participants 
All patients were recruited from the Autonomic Unit, National Hospital for Neurology and 
Neurosurgery, Queen Square, UK between 2004 and 2013. Idiopathic PD (without autonomic 
failure) patients were diagnosed using the UK Parkinson’s Disease Society Brain Bank 
diagnostic criteria. PD with autonomic failure (PD+AF) was defined as idiopathic PD with 
orthostatic hypotension (Systolic/Diastolic blood pressure fall > 20/10 mmHg) (8, 9) and 
abnormal BP responses to the Valsalva manoeuvre during phase II and phase IV in 
combination with impaired heart rate responses during deep breathing and orthostasis. MSA 
patients were diagnosed using Gilman’s criteria (10) for probable MSA. Only probable MSA 
patients with orthostatic hypotension were included in the study. 
All patients with PD had a good and sustainable response to levodopa treatment without 
features suggesting an atypical parkinsonian disorders. The sustainable response to levodopa 
was defined as a reported benefit after 3 years from starting levodopa by the treating 
clinician. Participants had no previous history of cardiovascular disease, diabetes mellitus or 
other illnesses that could affect autonomic function. PD patients were asked to stop 
dopaminergic medications and other drugs that could interfere with autonomic function at 
least 12 hours before autonomic testing. 
Patients were referred to the Unit due to orthostatic symptoms and investigated for atypical 
parkinsonism. Only patients who underwent cardiovascular autonomic screening tests (AFT) 
and 24hr-ABPM during the same admission and not currently on anti-hypotensive 
medications were recruited in the study. In order to verify the efficacy of 24hr-ABPM in 
detecting OH using an autonomic diary protocol, a subgroup of patients who completed a 
diary as part of the ABPM were also included in the sensitivity analyses.  
Clinical history and evaluation of autonomic nervous system function 
Demographic data, such as age at testing, dopaminergic medications and disease duration 
were also noted. 
Cardiovascular autonomic screening tests (AFT) 
All patients underwent 10-minute 60 degrees head-up tilting (HUT) as part of the autonomic 
function tests (AFT) using the Autonomic Unit Queen Square protocols (11). Continuous 
beat-to-beat BP and heart rate were recorded online using digital photoplethysmography 
(Finapres, TNO-TPD, Biomedical Instrumentation), and electrocardiography (ECG), 
respectively. These variables were also recorded intermittently using upper arm 
sphygmomanometry at 1, 4, 7 and 10 minutes of HUT.  
24 hour-Ambulatory Blood Pressure and Heart Rate Monitoring (24hr-ABPM) 
All patients were fitted with the 24hr-ABPM (model 90207, Spacelabs™ Medical, Redmond, 
Washington) after their AFT as part of their autonomic investigations. The appropriate cuff 
size was selected depending on the mid-arm circumference according to the guidelines (12) 
on the non-dominant upper arm for monitoring. The centre of the cuff was placed over the 
brachial artery with the lower edge above the antecubital fossa. The 24hr-ABPM was 
initialized and the patient’s details and current medications were input in the system. The 
instructions including how to record blood pressure manually, remove and adjust the cuff, 
inactivate the monitor and how to record the details in the diary were explained. BP and HR 
were recorded every 20 minutes during the day (0800-2300) and every 60 minutes during the 
night (2300-0800). The average BP and HR were calculated for daytime, night-time and the 
entire 24-hour period. Patients were asked to record their symptoms in the diary during the 
day as well as the position and activity (lying down, sitting, and standing) at the same time. 
Patients were also asked to record additional BP readings in addition to the automated 
readings if they developed symptoms. Bed- and wake-up time were also recorded in order to 
determine the period of sleep. Patients were asked to perform postural challenges using a 5-
minute standing test 4 times throughout the day (at 1000, 1400, 1900 and 2100) (see 
Suplementary material). 
Patients were classified into 3 groups according to the guideline(3): dipper (BP fall during 
night-time>10% compared to daytime), absent nocturnal BP fall or non-dipper (BP fall 
during night-time<10% compared to daytime) and reverse nocturnal BP (BP higher during 
night-time than daytime)(3). Patients with an average daytime SBP >140 mmHg or DBP >90 
were defined as daytime hypertensives and those with nighttime SBP >125 or DBP >75 as 
nighttime hypertensives according to international guidelines (13).  
Statistical Analyses 
Data are presented as mean (± 1 SD) or median (inter-quartile range), where appropriate. 
Analysis of covariance was used for comparisons between the 3 groups for normally 
distributed data while the Kruskal-Wallis test was used if data were non-normally distributed. 
Mann-Whitney U tests were used to compare between 2 groups for non-normally distributed 
data and unpaired t-tests for normally distributed data with Bonferroni corrections. Chi-
square analyses were used for analysis of categorical variables.  
SBP and DBP responses from the 24hr-ABPM standing test with the greatest degree of BP 
reduction were compared with the BP and HR responses during HUT using a standard criteria 
of OH (SBP fall >20 mmHg or DBP fall >10 mmHg). Considering the BP responses during 
HUT as a gold standard test, sensitivity (Sn) of the 24hr-ABPM to detect OH was defined as 
the proportion of patients who have OH from a standing test during 24hr monitoring and the 
proportion of patients who have OH during laboratory HUT. Specificity (Sp) was defined as 
the proportion of patients who did not have OH during the standing test in 24hr monitoring 
and all patients who were correctly classified as not having OH from HUT. ROC (Receiver 
operating characteristic) analysis was used to evaluate the sensitivity and specificity in 
detecting OH from 24hr-ABPM and to calculate Sn and Sp using different BP cut-off points. 
ROC curves were plotted as Sn against 1-Sp and were used to determine the Sn and Sp of the 
24hr-ABPM in detecting a fall of 20-mmHg SBP and 10-mmHg DBP.  
An overall summary of the diagnostic performance of the 24hr BP profile was calculated 
using the area under the curve (AUC). The perfect discrimination for AUC is 1, which means 
the diagnostic test can perfectly differentiate between two conditions with both Sn and Sp 
equalling 100%. An AUC of 0.8 or higher shows excellent discrimination. An AUC of 0.5 or 
less indicates that the diagnostic accuracy is not different from random chance.  Statistical 
analyses were carried out using STATA 11.0 (STATA Corporation, College station, Texas, 
USA). All tests were 2-sided and a p value of <0.05 was considered significant. 
Results 
Demographic data 
74 patients (23 MSA, 18 PD+AF, 33 PD) were included in the analyses. Patients with 
PD+AF were significantly older than PD and MSA (both p<0.01) but there was no difference 
in age between MSA and PD (p=0.55). There was no difference in disease duration among 
groups (p=0.23). Dopaminergic treatment was more commonly used in patients with PD and 
PD+AF compared to those with MSA (MSA vs. PD+AF; p=0.01 and MSA vs. PD; p<0.01). 
There was no difference in the number of patients on dopaminergic medication among PD 
and PD+AF (p=0.53, Table 1).    
Cardiovascular responses to HUT  
Supine SBP and DBP were not significantly different between MSA, PD+AF, PD patients 
but there was a higher baseline HR in MSA patients. During head-up tilting (HUT), SBP was 
significantly lower in patients with MSA and PD+AF compared to PD (p<0.01). 
Correspondingly, BP falls during HUT were significantly lower in MSA and PD+AF when 
compared to PD. There were no difference in SBP and DBP during HUT between MSA and 
PD+AF (p=0.35 and p=0.90, respectively) but HR was significantly higher in MSA during 
HUT (Table 2). During HUT, all patients with MSA and PD+AF fulfilled the criteria of OH, 
whereas none of the PD patients met the criteria of OH during HUT.   
24 hour-Ambulatory BP Monitoring data 
MSA patients had significantly lower daytime SBP and DBP compared to PD patients (both 
p<0.01), whereas there was no difference between PD+AF and PD patients (p=0.34), as well 
as between MSA and PD+AF (p=0.17). Daytime average HR was not different among patient 
groups (p=0.28). During nighttime, there was a significantly higher SBP in PD+AF patients 
compared to PD (p=0.01), but no difference between MSA and PD (p=0.17) or MSA and 
PD+AF (p=0.11). Nighttime HR in MSA was greater than PD (p=0.03) but there was no 
difference between PD and PD+AF (p=0.06). The average SBP, DBP and HR in the 24-hour 
period were not different among groups (p>0.05).  
There were no differences in the number of patients with daytime and nighttime hypertension 
among groups (p>0.05). Nocturnal blood pressure dipping was significantly lower in MSA 
compared to PD (both p<0.01) but there was no difference between MSA and PD+AF (SBP; 
p=0.71 and DBP; p=0.55). The nocturnal HR fall was not different among patient groups 
(p=0.06). Correspondingly, MSA and PD+AF had a higher proportion of patients with 
abnormal BP circadian rhythms (both absent and reversed BP circadian rhythms; non-
dippers) than patients with PD (p<0.01 and p=0.04, respectively) but not between MSA and 
PD+AF (p=0.08). Patients with reversed BP circadian rhythms were significantly more 
common in MSA and PD+AF compared to those with PD (both p<0.01) but not between 
MSA and PD+AF (p=0.14). There was also no difference in the number of patients with an 
absent BP circadian rhythm among groups (p>0.05; Table 3). 
24hr SBP variability was significantly higher in MSA and PD+AF patients compared to PD 
(both p<0.01) but there was no difference in 24hr DBP variability between MSA and PD+AF 
(p=0.32). There was a significantly lower daytime DBP variability in PD+AF compared to 
PD.  MSA patients had significantly lower 24hr HR variability compared to PD (p<0.01). 
SBP, DBP and HR variability during nighttime were not different among groups (p>0.05; 
Table 4).  
24hr-ABPM and patient-report diary  
Out of 74, 44 (59%) patients completed the diary during the 24hr-ABPM monitoring. There 
was no difference in the number of patients who completed the diary among groups; 17(74%) 
MSA, 11(61%) PD+AF and 16 (48%) PD patients. For the purpose of the sensitivity and 
specificity analyses of 24hr-ABPM in detecting OH, patients were divided into those with 
and those without OH according to the BP responses during HUT. MSA and PD+AF patients 
were combined as a single group (OH+ group) and PD patients were a control group (OH-). 
The average supine SBP was significantly higher in patients with OH (OH+), but the mean 
DBP and HR were not different compared to patients without OH (OH-). During head-up 
tilting (HUT), SBP was significantly lower in OH+ compared to OH- (p<0.01). By definition, 
the degree of SBP and DBP falls during HUT were significantly greater in OH+ compared 
with OH- (p<0.01).  
Cardiovascular responses to HUT and standing test using ABPM 
With 24hr-ABPM, supine SBP, DBP and HR were not different between OH+ and OH- but 
the average SBP and DBP were significantly lower in OH+ during the standing test compared 
to OH-. The degree of orthostatic blood pressure (both SBP and DBP) fall was significantly 
greater in OH+ compared to OH- (p<0.05) but there was no difference for HR (Table 5). 
There was also a significant correlation between the orthostatic blood pressure changes 
during the standing tests (on 24-hr ABPM) and head-up tilt (Spearman’s Rho=0.48; p=0.01). 
ROC analysis for detecting OH during HUT and standing tests using ABPM with autonomic 
protocol diary. 
Using 24hr-ABPM, the AUC that distinguishes OH+ from OH- was 0.87 (95% CI, 0.75-
0.99). A fall of 20 mmHg or more in SBP showed a sensitivity and specificity of 82% and 
100% in differentiating OH+ from OH-, respectively. A DBP fall of 10 mmHg or more had a 
57% sensitivity and a 94% specificity to discriminate OH+ from OH- with an AUC of 0.75 
(Table 6). A 20 mmHg systolic BP fall criteria had a significantly higher efficacy in 
detecting OH compared to a 10-mmHg DBP fall using the 24hr-ABPM with the autonomic 
protocol diary (p<0.01). 
Discussion 
The aim of this study was to 1) examine 24hr-ABPM in patients with chronic autonomic 
failure (MSA+AF, PD+AF and PD) and 2) determine the effectiveness of 24hr-ABPM 
compared to standard orthostatic challenge testing (10 minute Head-up Tilt) in diagnosing 
orthostatic hypotension (OH) in these patients. The main findings in this study were that an 
abnormal circadian BP rhythm (either a blunted nocturnal fall of BP or a reversed nocturnal 
fall) occurred in about half of the patients with PD. This proportion was higher in PD+AF 
and in patients with MSA. In comparison to recent studies (5), the prevalence of an abnormal 
circadian BP rhythm in PD in the present study was similar whereas the prevalence of an 
abnormal circadian BP rhythm in MSA patients in the present study was higher (68% vs. 
96%, respectively). Another study was also found significantly higher nocturnal HR and 
lower nocturnal HR decline in MSA compared to PD patients (14).  These inconsistent results 
are likely to be explained by the fact that this study categorized patients with regards to a 
patient’s diagnosis and their autonomic function, whereas the previous study used only a 
diagnostic category (e.g., MSA patients without autonomic failure were included). 
Furthermore, a reversed nocturnal circadian BP pattern was more common in autonomic 
failure patients, presenting in more than 50% of MSA and PD+AF patients compared to only 
15% in PD patients. These findings suggest that even though a blunted nocturnal fall in 24hr 
BP profiles can often be seen among PD patients without autonomic failure, a reversed 
nocturnal circadian BP pattern is much more common in patients with autonomic failure 
(PD+AF and MSA). Daytime SBP variability was also higher in patients with autonomic 
failure, which could be due to greater fluctuations in BP in MSA and PD+AF during daily 
activities compared to patients without autonomic failure, and supports the idea that this 
value could also be an additional useful measurement in 24hr-ABPM in patients with 
suspected autonomic failure and/or orthostatic hypotension. The 24hr BP profiles in patients 
with MSA and PD+AF were relatively similar suggesting that 24hr-ABPM patterns cannot be 
used to discriminate between MSA and PD+AF.  
Human circadian rhythms are controlled by the suprachiasmatic nucleus (SCN) in the 
hypothalamus (15). The SCN projects afferent input to the paraventricular nucleus (PVN), 
which plays an important role in controlling various autonomic functions, such as stress 
responses and metabolism (16). Both sleep and physical activity have a large influence on BP 
and HR circadian changes, including the normal physiological blood pressure fall during 
sleep (17). Abnormal circadian BP rhythms are common in PD, PD+AF and MSA and it is 
important to note that the number of patients with a reversed circadian BP profile at night was 
significantly higher in PD+AF and MSA compared to PD (without AF). This finding 
suggests that autonomic dysfunction plays an important contributing role in the control of 
circadian BP rhythms. Abnormal circadian rhythm of body core temperature and blunted 
nocturnal falls of body core temperature were reported in patients with MSA but not in PD 
(18). As the circadian rhythm of body core temperature is a solid marker of SCN activity, the 
evidence of abnormal circadian rhythm and blunted nocturnal falls of body core temperature 
in the previous study together with the higher of proportion of patients with abnormal BP 
circadian rhythm in MSA in our study might reflect more widespread pathology of central 
autonomic network in MSA compared to PD.    
Although the cause of abnormal circadian BP rhythms in PD and MSA remains unclear, the 
involvement of SCN and PVN are likely to play an important contributing role (19). An 
abnormal circadian BP rhythm in MSA is supported by prior pathological studies showing 
pathological changes within both the paraventricular nucleus (20) and the suprachiasmatic 
nucleus (21) in MSA. In contrast to MSA, the neuronal loss and pathological involvement in 
these structures have never been reported in PD and PD+AF. Nevertheless, sleep dysfunction 
is common in both patients with PD and MSA and this can reduce the nocturnal blood 
pressure decline in addition to contributing to an abnormal BP circadian rhythm. The major 
cause of this problem includes REM (Rapid Eye Movement) sleep behavior disorder (RBD), 
obstructive sleep apnea (OSA) and excessive daytime somnolence (EDS). These features may 
partly explain the reason why abnormal circadian BP profiles frequently occur in both 
disorders. Unfortunately we did not specifically record sleep wake cycles (nor episodes of 
nocturia) during the 24hr-monitoring so we are not able to entirely exclude the influence of 
this on the prevalence of the nocturnal blood pressure dipping observed in the present study. 
Supine hypertension is a common feature in patients with autonomic failure (22) and is also 
associated with OH (2). It is thus very likely that supine hypertension contributed to the 
reversed circadian BP pattern in MSA and PD+AF patients in the present study. The cause of 
supine hypertension in MSA has been suggested to result from an inappropriate residual 
sympathetic tone (23). These findings also emphasize that the reversed circadian BP pattern 
from 24hr-ABPM is a shared phenomenon in both patients with autonomic failure from both 
pre- (MSA) and post-ganglionic (PD) lesions, rather than a disease-specific feature. 
The present study also showed that using an autonomic protocol diary alongside 24hr-ABPM 
is useful for helping diagnose patients with OH. Using the standard criteria of OH, this 
technique provides a reasonably high sensitivity (82%) and specificity (100%) to distinguish 
OH+ from OH- patients with parkinsonism. Nevertheless, a 20-mmHg fall of SBP has a 
significantly better efficacy in detecting OH from 24hr-ABPM when compared with a 10-
mmHg fall of DBP. A recent study reported that blood pressure recording on head-up tilt 
correctly reflected hypotension during ambulatory monitoring in only 33% of patients with 
autonomic failure (24). The dissimilarity may be explained by the more heterogeneous group 
of patients in that study and the differences in methodology (e.g., the potential benefit of 
using four sets of blood pressure measurements on standing tests during 24-hr blood pressure 
monitoring at different times of the day in the present study).  
Given that 24hr-ABPM is non-invasive, relatively simple tests to perform without a 
requirement of an autonomic laboratory, this technique should be included as part of 
autonomic investigations in suspected OH workups. An adjunct diary to 24hr BP monitoring 
can also provide additional information with regards to the effect of patient activities on BP 
and HR and their relation to symptoms. Such an approach would allow the clinician to make 
a connection between activities and BP/HR during events if symptoms develop (25).  
In conclusion, this study demonstrated that patients with PD+AF and MSA, who had a 
similar degree of orthostatic hypotension during HUT, generally have similar circadian BP 
and HR patterns as revealed by 24hr-ABPM. As abnormal circadian rhythms are similarly 
present in PD+AF and MSA, this suggests that the proportion of abnormal BP circadian 
patterns in 24hr-ABPM depends on the autonomic function rather than the diagnosis. 
Moreover, this study also demonstrated that 24hr-ABPM (especially SBP) can offer more 
information regarding OH in patients with autonomic failure if a patient-completed 
autonomic protocol diary containing postural challenges (standing) is used. This approach has 
reasonably high sensitivity and specificity in detecting OH.  
 
 
 
 
 
 
 
Table 1. Patient demographic data  
Variable MSA PD+AF PD 
Number 23 18 33 
% Male 48 44 67 
Age at testing;  Mean (SD), yrs 62+9 72+7*
$ 
64+10 
Disease duration;  Median (IQR), yrs 4 (3-6) 7 (4-10) 6 (2-10) 
% Dopaminergic treatment 39*
# 
78 85 
Values are mean+SD unless stated, * p<0.05 vs. PD, 
#
 p<0.05 vs. PD+AF, 
$
p<0.05 vs. 
MSA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Blood pressure and HR during supine and head-up tilting and orthostatic 
changes in MSA, PD+AF and PD patients 
Variable MSA (n=17) PD+AF (n=11) PD (n=16) 
HUT    
  Supine SBP 137+18 140+21 130+14 
  Supine DBP 81+11 75+15 75+10 
  Supine HR 77+9 69+4
$
 69+10
$
 
  Tilt SBP 95+19* 101+24* 126+16 
  Tilt DBP  60+13* 63+17* 76+10 
  Tilt HR 85+13 77+6
$
 76+11
$
 
  Orthostatic ∆SBP  -42+17* -39+17* -5+8 
  Orthostatic ∆DBP -20+12* -12+10* 0+5 
  Orthostatic ∆HR 8+6 8+5 7+5 
Values are mean+SD unless stated, *p<0.05 vs. PD, 
$
p<0.05 vs. MSA 
SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure; values in mmHg, 
Heart Rate=HR; value in bpm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 3. 24 hr-ABPM profiles in MSA, PD and PD+AF 
Variable MSA (n=23) PD+AF (n=18) PD (n=33) 
Daytime 
- Mean SBP 
- Mean DBP 
- Mean HR 
 
116+12* 
71+7* 
81+9 
 
122+13 
73+12 
75+7 
 
127+12 
77+9 
79+10 
Patients with daytime 
hypertension, % (n) 
4% (1/23) 6% (1/18) 18% (6/33) 
Nighttime 
- Mean SBP 
- Mean DBP 
- Mean HR 
 
119+12 
70+9 
72+11* 
 
127+16* 
72+13 
65+8 
 
115+12 
67+9 
66+8 
Patients with nighttime 
hypertension, % (n) 
30% (7/23) 50% (9/18) 24% (8/33) 
24-hour values 
- Mean SBP  
- Mean DBP 
- Mean HR 
 
117+11 
71+6 
80+9 
 
123+13 
72+11 
73+7 
 
125+11 
76+9 
76+9 
Patients with abnormal BP 
circadian rhythm, % (n) 
96% (22/23)* 78%(14/18)* 48% (16/33) 
Patients with absent BP 
circadian rhythm, % (n) 
39% (9/23) 22%(4/18) 33% (11/33) 
Patients with reversed BP 
circadian rhythm, % (n) 
57% (13/23)* 56%(10/18)* 15% (5/33) 
Mean Nocturnal BP/HR change 
- SBP (%) 
- DBP (%) 
- HR (%) 
 
+2.8 +9.0* 
-1.6 +10.8* 
-11.1+9.9 
 
+4.3 +14.7* 
-0.1 +20.7* 
-12.7+5.7 
 
-9.1 +8.9 
-12.9 +11.0 
-16.1+7.3 
Values are mean+SD unless stated, * p<0.05 vs. PD, 
#
 p<0.05 vs. PD+AF, 
$
p<0.05 vs. 
MSA 
SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure; values in mmHg, Heart 
Rate=HR; value in bpm. 
 
 
 
 
 
  
 
 
Table 4. 24 hr-ABPM BP and HR variability in MSA, PD and PD+AF 
Variable MSA (n=23) PD+AF (n=18) PD (n=33) 
BP variability 
Daytime 
- SBP  
- DBP  
- HR  
 
Nighttime 
- SBP  
- DBP  
- HR  
 
24-hr 
- SBP 
- DBP 
- HR  
 
 
15.6+5.2* 
10.0+2.9 
6.7+2.7* 
 
 
11.2+6.4 
7.9+3.6 
4.4+2.2 
 
 
15.5+4.5* 
10.2+2.3 
7.5+2.8* 
 
 
16.8+4.9* 
10.8+2.8* 
7.8+2.9 
 
 
12.8+5.3 
7.8+3.1 
5.5+2.7 
 
 
17.2+4.5* 
11.2+2.7 
8.4+2.6 
 
 
11.6+4.4 
8.9+2.6 
9.3+3.2 
 
 
9.5+4.1 
7.3+3.0 
4.8+2.4 
 
 
13.1+4.6 
9.9+3.0 
10.2+2.9 
Values are mean+SD, * p<0.05 vs. PD, 
#
 p<0.05 vs. PD+AF, 
$
p<0.05 vs. MSA 
SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure; values in mmHg, Heart 
Rate=HR; value in bpm. 
 
 
 
 
 
 
 
 
 
Table 5. Blood pressure and HR during supine, head-up tilting and orthostatic changes 
in patients without OH (PD) compared with patients with OH (MSA and PD+AF) 
Variable 
Patients with OH 
(MSA and PD+AF) 
Patients without OH 
(PD) 
Number of patients 28 16 
HUT 
  
  Supine SBP  138+16
£
 127+13 
  Supine DBP 79+11 74+9 
  Supine HR 73+8 70+7 
  Tilt SBP  100+19
ϕ£
 125+17 
  Tilt DBP 63+13
ϕ£
 75+8 
  Tilt HR 81+12
ϕ
 78+9 
  ∆SBP  -38+15£ -3+9 
  ∆DBP -16+11£ 1+5 
  ∆HR 8+6 8+4 
Standing test  
   Supine SBP 
   Supine DBP 
   Supine HR 
   Stand SBP 
   Stand DBP 
   Stand HR 
   ∆SBP  
   ∆DBP  
   ∆HR 
 
128+16 
75+13 
74+11 
99+14
ϕ£
 
62+11
ϕ£
 
84+12
ϕ
 
-29+19
£
 
-13+13
£
 
10+7 
 
128+18 
74+11 
74+10 
122+16 
78+12 
81+11 
-6+6 
4+6 
7+5 
Values are mean+SD, 
£
 p<0.01 vs. patients without OH, 
ϕ
p<0.01 vs. corresponding Supine 
SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure; values in mmHg, Heart 
Rate=HR; value in bpm. 
 
 
 
 
 
 
 
 
 
Table 6. Sensitivity analysis for 24 hr-ABPM in detecting orthostatic hypotension (OH)  
 
 
Sensitivity (%) 
 
Specificity (%) 
 
AUC 
(95% CI) 
BP 
- SBP fall > 20 mmHg 
- DBP fall > 10 mmHg 
 
 
 
82 
57 
 
 
100 
94 
 
 
0.91 (0.84-0.98) 
0.75 (0.64-0.87) 
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